Anil Chandraker

Blockade of T-cell costimulation prevents development of experimental chronic renal allograft rejection.

K. Nadeau, M. Sayegh, W. Hancock, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Regulatory functions of self-restricted MHC class II allopeptide-specific Th2 clones in vivo.

S. Khoury, M. Sayegh, N. Najafian, 2001, The Journal of clinical investigation.

Mechanisms of indirect allorecognition: characterization of MHC class II allopeptide-specific T helper cell clones from animals undergoing acute allograft rejection.

S. Khoury, M. Sayegh, A. Chandraker, 1998, Transplantation.

In vitro and in vivo immunomodulatory effects of RDP1258, a novel synthetic peptide.

M. Sayegh, M. Denton, A. Chandraker, 1999, Journal of the American Society of Nephrology : JASN.

CD28-B7-mediated T cell costimulation in chronic cardiac allograft rejection: differential role of B7-1 in initiation versus progression of graft arteriosclerosis.

R. Peach, M. Sayegh, M. Denton, 2001, The American journal of pathology.

Anti-CD154 or CTLA4Ig obviates the need for thymic irradiation in a non-myeloablative conditioning regimen for the induction of mixed hematopoietic chimerism and tolerance.

M. Sykes, M. Sayegh, A. Chandraker, 1999, Transplantation.

Hepatocyte growth factor prevents the development of chronic allograft nephropathy in rats.

K. Matsumoto, J. Wang, M. Sayegh, 2001, Journal of the American Society of Nephrology : JASN.